Naltrexone Hydrochloride Compositions
Details for Australian Patent Application No. 2007202618 (hide)
International Classifications
Event Publications
28 June 2007 Complete Application Filed
12 July 2007 Application Open to Public Inspection
Published as AU-B-2007202618
29 January 2009 Application Accepted
Published as AU-B-2007202618
27 August 2009 Section 223 Application Allowed
Euro-Celtique S.A. The time in which to pay an acceptance fee has been extended to 29 Jul 2009. Address for service in Australia - Wrays Ground Floor 56 Ord Street West Perth WA 6005 2008
3 September 2009 Standard Patent Sealed
10 November 2011 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 08 Sep 2011. Address for service in Australia - Wrays 56 Ord Street West Perth WA 6005
29 March 2012 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 08 Sep 2011
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007202619-Human Anti-OPGL Neutralizing Antibodies as Selective OPGL, Pathway Inhibitors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser